ZBED3 and metastatic malignant neoplasm in the lymph nodes: Furthermore, ZBED3 displays significant correlations with various clinical parameters, including enhanced lymph node metastasis, advanced TNM stages, elevated Ki67 expression, and unfavorable clinical outcomes [31, 32].